on 6 April 2022, Shenzhen Zhong Ji Health Science Company Limited signed a commodity supply contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd. The signing of the Supply Contract marks the formal formation of a strategic partnership between the two parties, which is the first step of the Group's retail coverage in Mainland China after obtaining the legal rights to distribute ZJ1 VC Extended-Release Tablets, a biological product from the United States, on the Mainland. The Group's next endeavour is continuously enhancing the development and collaboration with the top 100 offline pharmaceutical retailers in China, with a view to developing a more convenient physical channel for the public.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 HKD | +12.24% | -9.84% | +62.96% |
1st Jan change | Capi. | |
---|---|---|
+62.96% | 11.44M | |
-8.05% | 49.99B | |
-5.83% | 30.63B | |
+55.48% | 27.62B | |
+28.84% | 25.14B | |
+15.50% | 17.64B | |
+1.63% | 12.92B | |
+15.48% | 10.69B | |
+15.38% | 8.21B | |
-27.24% | 7.7B |
- Stock Market
- Equities
- 767 Stock
- News Zhong Ji Longevity Science Group Limited
- Shenzhen Zhong Ji Health Science Company Limited Signs A Commodity Supply Contract with Sinopharm Holdings Hubei Guoda Pharmacy Co,. Ltd